AN
50
-5
DVN
14
-6
FOXA
52
-14
TSN
50
-2
FRT
41
-2
COST
57
-6
KEY
43
-3
HAS
30
-2
DIS
85
3
STZ
52
-6
RL
69
-4
FFIV
66
-4
MTCH
20
-8
ADSK
66
-4
WEC
53
5
PYPL
52
-2
SLG
57
-3
EMR
71
-3
ICE
59
-3
A
37
-2
AN
50
-5
DVN
14
-6
FOXA
52
-14
TSN
50
-2
FRT
41
-2
COST
57
-6
KEY
43
-3
HAS
30
-2
DIS
85
3
STZ
52
-6
RL
69
-4
FFIV
66
-4
MTCH
20
-8
ADSK
66
-4
WEC
53
5
PYPL
52
-2
SLG
57
-3
EMR
71
-3
ICE
59
-3
A
37
-2
Financhill
Back

Citius Oncology Quote, Financials, Valuation and Earnings

Trump's IRS Hands Massive 'Victory Gift' To 401K Owners

Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
1

CTOR
Citius Oncology

Last Price:
1.04
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

America's enemies are regrouping & it may sucker punch your savings

Click here to learn more.

Citius Oncology Price Quote

$1.04
-0.02 (-2.71%)
(Updated: November 16, 2024 at 5:14 AM ET)

Citius Oncology Key Stats

Sell
1
Citius Oncology (CTOR) is a Sell
Day range:
$1.03 - $1.13
52-week range:
$0.93 - $4.42
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
51.7K
Avg. volume:
95.2K
1-year change:
0%
Market cap:
$75.5M
Revenue:
$0
EPS:
$0

How Much Does Citius Oncology Make?

Data Unavailable

Is Citius Oncology Growing As A Company?

Data Unavailable

Citius Oncology Stock Price Performance

  • Did Citius Oncology Stock Go Up Last Month?
    Citius Oncology share price went up by 6% last month
  • Did CTOR's Share Price Rise Over The Last Year?
    CTOR share price rose by 0% over the past 1 year

What Is Citius Oncology 52-Week High & Low?

Citius Oncology Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Citius Oncology?

Data Unavailable

Is Citius Oncology Cash Flow Positive?

Data Unavailable

Citius Oncology Return On Invested Capital

Data Unavailable

Citius Oncology Earnings Date & Stock Price

Citius Oncology Competitors

  • Who Are Citius Oncology's Competitors?
    Below is a list of companies who compete with Citius Oncology or are related in some way:
    • Citius Pharmaceuticals Inc (CTXR)
    • iBio Inc (IBIO)
    • Merck & Co Inc (MRK)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Citius Oncology Dividend Yield

Citius Oncology Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many CTOR shares are owned by institutional investors?
    2.3K CTOR shares are owned by institutional investors
  • How many CTOR shares are owned by insiders?
    0 CTOR shares are owned by insiders